Subscribe free

Intestine and Lower Gastrointestinal Tract ·

Colon cancer metastasis distribution shifts significantly over five years

A dramatic near 70% decline in resectable or borderline metastatic colorectal cancer cases was observed over the past five years. Researchers noted significant changes in metastasis distribution; specifically, m1a pathological cases decreased while m1c cases rose from 26.6% to 32.4%. Notably, stage 4b emerged as a strong predictor for hepatic metastasis. These findings underscore the necessity for adapting interdisciplinary treatment strategies in response to evolving metastatic patterns.

Journal Article by Stephens KR, Donica WRF (…) Martin RCG et 4 al. in Ann Surg Oncol

© 2024. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

All papers in Intestine and Lower Gastrointestinal Tract →